ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | – | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -99.9% | 200 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000,000 | – | 200 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COWEN AND COMPANY, LLC | 4,331,020 | $7,882,000 | 1.31% |
| RTW INVESTMENTS, LP | 6,869,281 | $12,502,000 | 0.35% |
| A.R.T. Advisors, LLC | 14,140 | $26,000 | 0.04% |
| Hudson Bay Capital Management LP | 975,000 | $1,774,000 | 0.03% |
| Secure Asset Management, LLC | 10,000 | $18,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,774,935 | $3,230,000 | 0.01% |
| FNY Investment Advisers, LLC | 9,900 | $18,000 | 0.01% |
| Squarepoint Ops LLC | 322,225 | $586,000 | 0.01% |
| LMR Partners LLP | 107,912 | $196,000 | 0.01% |
| Virtu Financial LLC | 17,147 | $31,000 | 0.00% |